BRÈVE

sur Catheter Precision, Inc

Catheter Precision, Inc. Secures Initial Orders for LockeT from Prominent Hospitals

Catheter Precision, Inc., a medical device company specializing in electrophysiology products, announced initial orders for its new product, LockeT, from notable medical institutions including Ronald Reagan UCLA Medical Center and Rady Children’s Hospital in San Diego. This announcement follows the expansion of the company's U.S. sales and clinical team in anticipation of LockeT's national launch.

David Jenkins, CEO of Catheter Precision, highlighted the increase in LockeT evaluations and purchase orders following the expansion of the commercial team. Marie-Claude Jaques, the Chief Commercial Officer, noted the addition of eight new representatives and several hospitals lined up for upcoming LockeT evaluations. LockeT, a Class 1 FDA-registered device, facilitates hemostasis after vascular catheter access, representing a promising advancement in medical device technology.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Catheter Precision, Inc